戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 namide adenine dinucleotide synthetase and 3-phosphoinositide dependent kinase-1.
2 3,4,5-P(3)-dependent serine/threonine kinase phosphoinositide-dependent kinase 1.
3 Balpha/Akt phosphorylation and activation by phosphoinositide-dependent kinase 1.
4 also binds to the Akt kinase mTORC2, but not phosphoinositide-dependent kinase 1.
5 ess effective substrates for upstream kinase phosphoinositide-dependent kinase 1.
6 e plasma membrane where it co-localizes with phosphoinositide-dependent kinase-1.
7  and brain slices by inhibiting its upstream phosphoinositide-dependent kinase-1.
8  requires novel PKC isoform activity and not phosphoinositide-dependent kinase-1.
9 rylation of the activation T-loop of Akt1 by phosphoinositide-dependent kinase-1.
10  activity of PI3K and the phosphorylation of phosphoinositide-dependent kinase 1, Akt, and IkappaB ki
11 hosphorylation of Thr(308) and Ser(473) by 3-phosphoinositide-dependent kinase-1 and 2 (PDK1 and PDK2
12 ion of Akt and its upstream regulators PI3K, phosphoinositide-dependent kinase-1 and integrin-linked
13                                              Phosphoinositide-dependent kinase-1 and phosphoinositide
14                                 We implicate phosphoinositide-dependent kinase-1 and PKCdelta autopho
15 e IP-10 promoter, and that the kinases PI3K, phosphoinositide-dependent kinase 1, and Akt act as inte
16  protein kinase, AGC2-1, regulated by the 3'-phosphoinositide-dependent kinase-1 (AtPDK1).
17 osphorylation of the Akt/PKB upstream kinase phosphoinositide-dependent kinase-1, but also its downst
18 d also demonstrated indirectly activation of phosphoinositide-dependent kinase-1 by MBP.
19 ted similarly to S6K1 by the PI3-K effectors phosphoinositide-dependent kinase 1, Cdc42, Rac, and pro
20 By binding to the PH domains of both Akt and phosphoinositide-dependent kinase-1, D3-phosphorylated p
21  ARE disruption also results in constitutive phosphoinositide-dependent kinase 1 gain of function.
22 xtracellular signal-regulated kinase 1/2 and phosphoinositide-dependent kinase 1 in response to many
23                           Here, we show that phosphoinositide-dependent kinase 1 is activated in memb
24 K (phosphatidylinositol 3-kinase) and PDK-1 (phosphoinositide-dependent kinase-1) kinases along with
25                   Phosphorylated (activated) phosphoinositide-dependent kinase 1, mitogen-activated p
26 hese molecules and by a lack of p110delta, 3-phosphoinositide-dependent kinase-1 or Akt3.
27  affecting upstream kinases, such as PI3k or phosphoinositide-dependent kinase-1, or members of other
28 at the plasma membrane (PM), including the 3-phosphoinositide-dependent kinase 1 orthologs Pkh1/Pkh2
29 5 min of training, in which phosphorylated 3-phosphoinositide-dependent kinase-1 (p-PDK1) is increase
30  to be phosphorylated by its upstream kinase phosphoinositide-dependent kinase 1 (PDK-1), 2) the matu
31 protein 90 (Hsp90) from its client protein 3-phosphoinositide-dependent kinase 1 (PDK-1), a major Akt
32 e in the catalytic loop is phosphorylated by phosphoinositide-dependent kinase 1 (PDK-1).
33                        The identification of phosphoinositide-dependent kinase-1 (PDK-1) as an activa
34 the effect of OSU-03012, a celecoxib-derived phosphoinositide-dependent kinase-1 (PDK-1) inhibitor, o
35 s identified as a novel potent and selective phosphoinositide-dependent kinase-1 (PDK-1) inhibitor.
36                                              Phosphoinositide-dependent kinase-1 (PDK-1) is a serine-
37                                      Because phosphoinositide-dependent kinase-1 (PDK-1) is required
38 f Akt activation through the inhibition of 3-phosphoinositide-dependent kinase-1 (PDK-1) represents a
39                                            3-Phosphoinositide-dependent kinase-1 (PDK-1) was identifi
40 tion in PC-3 cells through the inhibition of phosphoinositide-dependent kinase-1 (PDK-1) with IC(50)
41    A critical component of this pathway is 3-phosphoinositide-dependent kinase-1 (PDK-1), a PH domain
42 Exendin-4 increased the phosphorylation of 3-phosphoinositide-dependent kinase-1 (PDK-1), AKT, and pr
43 tion of the activation loop catalyzed by the phosphoinositide-dependent kinase-1 (PDK-1).
44  antitumor effects through the inhibition of phosphoinositide-dependent kinase-1 (PDK-1)/Akt signalin
45 his study identifies the recently discovered phosphoinositide-dependent kinase 1, PDK-1, as a regulat
46             Thr-308 is phosphorylated by the phosphoinositide-dependent kinase-1, (PDK-1), whereas th
47 se of Cdc37 and concomitant association of 3-phosphoinositide dependent kinase 1 (PDK1) to activate S
48 taining at a minimum ERK1/2, Akt, Rsk, and 3-phosphoinositide dependent kinase 1 (PDK1).
49 ) via phosphatidyl inositol-3-kinase (PI3K), phosphoinositide-dependent kinase 1 (PDK1 or PDPK1), and
50 with small interfering RNA (siRNA) targeting phosphoinositide-dependent kinase 1 (PDK1) along with ci
51 tion of Thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser473 wi
52 is AGCVIIIa kinases are substrates for the 3-phosphoinositide-dependent kinase 1 (PDK1) and that tran
53      Here, we report the identification of 3-phosphoinositide-dependent kinase 1 (PDK1) as a key regu
54                      The identification of 3-phosphoinositide-dependent kinase 1 (PDK1) as one of the
55                        We demonstrate that 3-phosphoinositide-dependent kinase 1 (PDK1) has an essent
56 and eEF2k activity is lost in cells in which phosphoinositide-dependent kinase 1 (PDK1) has been gene
57                                            3-Phosphoinositide-dependent kinase 1 (PDK1) has previousl
58                                              Phosphoinositide-dependent kinase 1 (PDK1) is a critical
59                                              Phosphoinositide-dependent kinase 1 (PDK1) is a pleiotro
60                                              Phosphoinositide-dependent kinase 1 (PDK1) is at the hub
61                            We show here that phosphoinositide-dependent kinase 1 (PDK1) is essential
62                                            3-Phosphoinositide-dependent kinase 1 (PDK1) is the first
63                    We recently reported that phosphoinositide-dependent kinase 1 (PDK1) partially cor
64 and the phosphatidylinositol 3-kinase (PI3K)/phosphoinositide-dependent kinase 1 (PDK1) pathway.
65  the carboxy-terminal kinase domain, and the phosphoinositide-dependent kinase 1 (PDK1) phosphorylate
66 In this study, we show that phosphorylated 3-phosphoinositide-dependent kinase 1 (PDK1) phosphorylate
67  serine and threonine phosphorylation by the phosphoinositide-dependent kinase 1 (PDK1) protein kinas
68                       Here, we report that 3-phosphoinositide-dependent kinase 1 (PDK1) regulates epi
69 e show that c-Jun regulates transcription of phosphoinositide-dependent kinase 1 (PDK1) with a concom
70                                              Phosphoinositide-dependent kinase 1 (PDK1), a downstream
71 th skeletal muscle-specific deficiency of 3'-phosphoinositide-dependent kinase 1 (PDK1), a key compon
72  the consequences of genetic manipulation of phosphoinositide-dependent kinase 1 (PDK1), a rate-limit
73 robing the phosphorylation of p90-S6 kinase, phosphoinositide-dependent kinase 1 (PDK1), and Akt.
74 dent on phosphoinositide 3-kinase (PI3K) and phosphoinositide-dependent kinase 1 (PDK1), and Dex indu
75 c1 GTPases, and the serine/threonine kinases phosphoinositide-dependent kinase 1 (PDK1), mammalian ta
76  interaction with its upstream kinase, the 3-phosphoinositide-dependent kinase 1 (PDK1), which phosph
77  an allosteric site on the Ser/Thr kinase, 3-phosphoinositide-dependent kinase 1 (PDK1)--the PDK1-int
78 n-like growth factor 1 receptor (IGF-IR) and phosphoinositide-dependent kinase 1 (PDK1).
79 Src signaling, leading to PI3K activation of phosphoinositide-dependent kinase 1 (PDK1).
80         PAK activity is regulated in part by phosphoinositide-dependent kinase 1 (PDK1).
81 Akt is activated by the phosphorylation of 3-phosphoinositide-dependent kinase 1 (PDK1).
82 to be under the control of Rho GTPases and 3-phosphoinositide-dependent kinase 1 (PDK1).
83 ude phosphoinositide 3-kinase (PI 3-K) and 3-phosphoinositide-dependent kinase 1 (PDK1).
84              The phosphoinositide 3-kinase/3-phosphoinositide-dependent kinase 1 (PDK1)/Akt signaling
85                                            3-phosphoinositide-dependent kinase-1 (PDK1) also upregula
86  of the kinase domain is phosphorylated by 3-phosphoinositide-dependent kinase-1 (PDK1) and Ser-473 i
87 e translocation and subsequent activation by phosphoinositide-dependent kinase-1 (PDK1) and the mecha
88         We report here that co-expression of phosphoinositide-dependent kinase-1 (PDK1) and the phosp
89                                              Phosphoinositide-dependent kinase-1 (PDK1) controls the
90                                           3'-Phosphoinositide-dependent kinase-1 (PDK1) has been impl
91                                              Phosphoinositide-dependent kinase-1 (PDK1) is a key sign
92                                              Phosphoinositide-dependent kinase-1 (PDK1) is a master k
93                                              Phosphoinositide-dependent kinase-1 (PDK1) is a serine/t
94                                            3-Phosphoinositide-dependent kinase-1 (PDK1) is a ubiquito
95                                            3'Phosphoinositide-dependent kinase-1 (PDK1) is essential
96  (PRK2)-interacting fragment (PIF) pocket of phosphoinositide-dependent kinase-1 (PDK1) was proposed
97              One target of PI3-K activity is phosphoinositide-dependent kinase-1 (PDK1), which in tur
98 regulation of ROS appeared to be mediated by phosphoinositide-dependent kinase-1 (PDK1), which was hy
99 allosteric proteins: h-Ras, caspase-1, and 3-phosphoinositide-dependent kinase-1 (PDK1).
100 and stabilizes the mRNA of the AKT activator phosphoinositide-dependent kinase-1 (PDK1).
101 pha can spatially restrict the activity of 3-phosphoinositide-dependent kinase-1 (PDK1).
102                                           3'-Phosphoinositide-dependent-Kinase-1 (PDK1) is a master r
103 ivated protein kinase (PAK) 1 on Thr423 (the phosphoinositide-dependent kinase-1 [PDK1] site) was att
104 9-based screen and demonstrated that loss of phosphoinositide-dependent kinase-1 (PDPK1) enhances the
105                           CaM-K kinase and 3-phosphoinositide dependent-kinase-1 phosphorylate threon
106                                              Phosphoinositide-dependent kinase-1 phosphorylated the a
107 target of rapamycin/p70(S6K), independent of phosphoinositide-dependent kinase 1/PKB activation.
108 and that blockade of its upstream kinase, 3'-phosphoinositide-dependent kinase 1, potently inhibits t
109 on of Ala for a Phe of the docking motif for phosphoinositide-dependent kinase-1 prevented activation
110 e signaling components downstream of PI3K, 3-phosphoinositide-dependent kinase 1, protein kinase B (P
111 ctivation of phosphatidylinositol 3'-kinase, phosphoinositide-dependent kinase-1, protein kinase C, s
112        We found that mice lacking the kinase phosphoinositide-dependent kinase 1 selectively lack LC.
113                              Deletion of the phosphoinositide-dependent kinase 1 target kinases, ribo
114 p is well established to be catalyzed by the phosphoinositide-dependent kinase 1, the mechanism of ph
115 weak TCR signals were sufficient to activate phosphoinositide-dependent kinase-1 to phosphorylate AKT
116 so induce conformational changes that permit phosphoinositide-dependent kinase-1 to phosphorylate the
117 n of Akt/PKB, but not its upstream activator phosphoinositide-dependent kinase-1, to the plasma membr
118 ne of the key effectors of this cascade, the phosphoinositide-dependent kinase-1, were found to be de

 
Page Top